Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction-Reference-Cited by-同舟云学术

Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction

Published:2012-12 Issue:12 Volume:14 Page:1338-1347
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Santhanakrishnan Rajalakshmi¹²,Chong Jenny P.C.¹,Ng Tze P.²,Ling Lieng H.²,Sim David³,Toh G. Leong Kui⁴,Shuan D. Yeo Poh⁵,Ong Hean Y.⁶,Jaufeerally Fazlur⁷,Wong Raymond⁸,Chai Ping⁸,Low Adrian F.²,Richards Arthur Mark¹²,Lam Carolyn S.P.¹²

Affiliation:

1. Cardiovascular Research Institute; National University of Singapore; Singapore

2. Yong Loo Lin School of Medicine; National University of Singapore; Singapore

3. National Heart Centre Singapore; Singapore

4. Changi General Hospital; Singapore

5. Tan Tock Seng Hospital; Singapore

6. Khoo Teck Puat Hospital; Singapore

7. Singapore General Hospital; Singapore

8. National University Heart Centre Singapore; Singapore

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfs130/fullpdf

Reference32 articles.

1. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology;McMurray;Eur Heart J,2012

2. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients;Januzzi;Eur Heart J,2006

3. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure;Bayes-Genis;Eur J Heart Fail,2012

4. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure;Pascual-Figal;Eur J Heart Fail,2011

5. Growth differentiation factor 15 in different stages of heart failure: potential screening implications;Wang;Biomarkers,2010

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient;2024-09-04

2. Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient;2024-09-04

3. 2023 SFMU/GICC-SFC/SFGG expert recommendations for the emergency management of older patients with acute heart failure. Part 1: Prehospital management and diagnosis;Archives of Cardiovascular Diseases;2024-09

4. Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly;Hormones;2024-04-18

5. Direct comparison of the diagnostic performance of growth differentiation factor 8 in pediatric versus adult heart failure;Clinica Chimica Acta;2024-04